Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
Argus Health
QuintilesIMS
US Army
Chubb
Cantor Fitzgerald
Express Scripts
Farmers Insurance

Generated: October 16, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for erythromycin and what is the scope of erythromycin patent protection?

Erythromycin is the generic ingredient in fifty-two branded drugs marketed by Mayne Pharma, Parke Davis, Warner Chilcott Llc, Hospira, Arbor Pharms Llc, Barr, Mylan Pharms Inc, Altana, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Syosset, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Dista, Dow Pharm, Paddock Llc, Taro, Arbor Pharms Inc, Merz Pharms, Saptalis Pharms, Hi Tech Pharma, Alpharma Us Pharms, Lilly, Perrigo New York, Renaissance Pharma, Wockhardt Bio Ag, Westwood Squibb, Ivax Sub Teva Pharms, Johnson And Johnson, Solvay, Robins Ah, Amneal Pharms Co, Watson Labs, G And W Labs Inc, Life Labs, Ani Pharms Inc, Ross Labs, Pharmacia And Upjohn, Naska, Wyeth Ayerst, Mylan, Alra, Abbott, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Teva Parenteral, Bristol, Warner Chilcott, Lederle, Purepac Pharm, Bristol Myers Squibb, and Pfizer, and is included in one hundred and twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and three drug master file entries for erythromycin. Thirty-five suppliers are listed for this compound.

Pharmacology for ERYTHROMYCIN
Medical Subject Heading (MeSH) Categories for ERYTHROMYCIN
Synonyms for ERYTHROMYCIN
1334-29-8
1334-39-0
33H58I7GLQ
3847-29-8
4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin
4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin (1:1)
847E298
AC1L2G7Z
AC1Q5R2M
Azithromycin lactobionate
C37H67NO13.C12H22O12
C49H89NO25
CA000798
CHEMBL1200506
CHEMBL3786307
D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1)
D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1) (9CI)
D02009
EINECS 223-348-7
Erythrocin Lactobionate IV
Erythromycin 4-O-beta-D-galactopyranosyl-D-gluconate (salt)
erythromycin lactobionate
Erythromycin lactobionate (1:1) (salt)
Erythromycin lactobionate (JP17/USP)
Erythromycin lactobionate [JAN]
Erythromycin mono(4-O-beta-D-galactopyranosyl-D-gluconate) (salt)
Erythromycin, 4-O-beta-D-galactopyranosyl-D-gluconate (salt)
ERYTHROMYCIN; LACTOBIONIC ACID
Erythromycin. compd. with lactobionic acid
ERYTHROMYCINLACTOBIONATE
Lactobionic acid compd. with erythromycin (1:1)
Lactobionic acid, compd. with erythromycin (1:1)
LS-87509
MolPort-039-062-122
n-2,10-dion(1:1)
Q-201067
SCHEMBL41566
UNII-33H58I7GLQ

US Patents and Regulatory Information for ERYTHROMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc ERY-TAB erythromycin TABLET, DELAYED RELEASE;ORAL 062298-002 Approved Prior to Jan 1, 1982 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alra ERYZOLE erythromycin ethylsuccinate; sulfisoxazole acetyl GRANULE;ORAL 062758-001 Jun 15, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Arbor Pharms Llc ERYTHROMYCIN erythromycin TABLET;ORAL 061621-002 Approved Prior to Jan 1, 1982 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
Argus Health
QuintilesIMS
US Army
Chubb
Cantor Fitzgerald
Express Scripts
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.